Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 31, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Nanosecond pulse lasers for retinal applications.

John P M Wood¹, Malcolm Plunkett, Victor Previn

¹South Australian Institute of Ophthalmology, Ophthalmic Research Laboratories, Level 2 Hanson Institute, IMVS, Adelaide, South Australia, Australia. john.wood@health.sa.gov.au

Lasers in Surgery and Medicine

|July 16, 2011

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Australian and New Zealand Glaucoma Society (ANZGS) Consensus on Interventional Glaucoma.

Clinical & experimental ophthalmology·2026

Same author

Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial.

Nature medicine·2026

Same author

Immunohistochemical optimization of a panel of antibodies against amyloid precursor protein for immunodetection of axonal injury in neurologic diseases of sheep.

Veterinary pathology·2026

Same author

Investigation into the use of a chitosan scaffold for tarsal plate substitution in eyelid reconstruction.

Regenerative biomaterials·2025

Same author

A Multitrait Polygenic Risk Score for Open-Angle Glaucoma Stratifies Risk of Pigmentary Glaucoma in Pigment Dispersion Syndrome.

Ophthalmology. Glaucoma·2025

Same author

Laser-induced histopathological changes to the retina: A review.

Survey of ophthalmology·2025

New nanosecond lasers offer a wider therapeutic range for retinal treatments compared to conventional lasers, minimizing collateral damage to photoreceptors. This advancement in laser technology shows promise for treating retinal diseases more effectively.

Area of Science:

Ophthalmology
Biomedical Engineering
Laser Physics

Background:

Conventional thermal lasers used for retinal disorders cause collateral photoreceptor damage.
There is a need for laser treatments with a greater therapeutic range to minimize damage.

Purpose of the Study:

Evaluate a 3-nanosecond pulse laser for retinal treatment.
Determine optimal parameters for maximizing therapeutic range while avoiding collateral damage.
Compare nanosecond laser performance against standard continuous wave (CW) lasers.

Main Methods:

Porcine ocular explants with apposed neuroretina were used.
Calcein-AM assay and histological methods assessed retinal pigmented epithelium (RPE) cell viability.
Three nanosecond pulse lasers (speckle- and gaussian-beam profiles) were compared to a 100 ms CW 532 nm laser.

More Related Videos

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

Published on: November 20, 2016

Related Experiment Videos

Last Updated: May 31, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

Published on: November 20, 2016

Main Results:

Nanosecond lasers demonstrated significantly lower RPE kill thresholds compared to CW lasers.
Therapeutic range ratios were substantially more favorable for nanosecond lasers (3.6:1 speckle-beam, 2.5:1 gaussian-beam) than for CW lasers (1.3:1).
Visible effect thresholds (VET) were also lower for nanosecond lasers.

Conclusions:

Nanosecond lasers, especially with a speckle-beam profile, offer a wider therapeutic energy range for RPE treatment.
This wider range allows treatment without damaging the apposed retina, unlike conventional CW lasers.
These findings have significant implications for improving retinal disease treatment outcomes.